LAC countries participation: ERAPerMed call 2020
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
LAC countries participation: ERAPerMed call 2020
Mauricio García-Franco, Coordination Unit
GA-ID: 779282
National Health School, National Institute of Health Carlos III (ISCIII), Madrid, 07th-08th November 2019
EULAC-PerMed Summer School
Personalised Medicine Research in the Health System
ERAPerMed – Content About ERA PerMed JTC 2018 JTC 2019 JTC 2020 Steps of a Call
ERA PerMed – ERA NET on Personalised Medicine
Time frame: 1 December 2017 – 30 November 2022
Consortium: 32 funding organisations from 23 countries (AT, BE, CA, DE, DK, ES, EE, FI,
FR, HR, HU, IE, IL, IT, LV, LU, NL, NO, PL, RO, SE, SI, TR)
The biggest ERA Net in health
19 EU countries
3 associated countries (H2020) : IL, NO, TR
1 third country: CA
23 countries 5 regions
32 partners ES (Navarre, Catalane)
IT (Lombardy)
DE (Saxony)
Coordination: CA (Québec)
Instituto de Salud Carlos III
(ISCIII), SPAIN
Joint Transnational Calls (JTCs)
1 Call cofunded by the EC 2018
3 Calls non-cofunded : 2019, 2020, 2021
ERA PerMed – ERA NET on Personalised Medicine
Time frame: 1 December 2017 – 30 November 2022
Consortium: 32 funding organisations from 23 countries (AT, BE, CA, DE, DK, ES, EE, FI,
FR, HR, HU, IE, IL, IT, LV, LU, NL, NO, PL, RO, SE, SI, TR)
The biggest ERA Net in health
19 EU countries
3 associated countries (H2020) : IL, NO, TR
1 third country: CA
ERA PerMed and ICPerMed
are closely connected.
23 countries 5 regions ICPerMed Action Plan and SRIA are
32 partners ES (Navarre, Catalane) consulted during the preparation of
IT (Lombardy) the calls
DE (Saxony)
Coordination: CA (Québec) https://www.
Instituto de Salud Carlos III icpermed.eu/
(ISCIII), SPAIN
Joint Transnational Calls (JTCs) www.erapermed.eu
1 Call cofunded by the EC 2018
3 Calls non-cofunded : 2019, 2020, 2021 (decision to go adopted on 12/09/2019)
Source: ERA PerMed ANR, France
ERAPerMed Definition of Personalised Medicine: Stated in the Strategic Research and Innovation Agenda (SRIA) of PerMed, adopted from the H2020 advisory group*: • “Personalised Medicine refers to a medical model using characterisation of individuals’ phenotypes and genotypes (e.g. molecular profiling, medical imaging, lifestyle data) for tailoring the right therapeutic strategy for the right person at the right time, and/or to determine the predisposition to disease and/or to deliver timely and targeted prevention.” * European Commission. Advice for 2016/2017 of the Horizon 2020 Advisory Group for Social Challenge 1, “Health, Demographic Change and Wellbeing
ERAPerMed – Structure
WP1 - COORDINATION & MANAGEMENT
EC cofunded call WP6 - ADDITIONAL
WP2+WP3+WP4+WP5 NON COFUNDED CALLS
WP 7 - STRATEGIC SUPPORT ACTIVITIESERAPerMed – Structure
EC cofunded call
WP 2 - PREPARATION AND LAUNCH OF
THE EU CO-FUNDED CALL
WP 3 – EVALUATION & PROPOSAL
SELECTION OF THE EU CO-FUNDED
CALL
WP 4 - FOLLOW UP AND MONITORING OF THE EU CO-
FUNDED PROJECTS
WP 5 - COMMUNICATION AND EXPLOITATION OF RESULTS OF
THE EU CO-FUNDED CALLERAPerMed – Content About ERA PerMed JTC 2018 JTC 2019 JTC 2020 Steps of a Call
ERAPerMed – EU co-funded JTC 2018
19 EU countries
3 associated countries (to Horizon 2020):
Turkey, Norway, Israel
1 third country: Canada
31 Partners 23 Countries 5 regions
Joint Call Secretariat (JCS) Countries´ ex ante Budget
Instituto de Salud Carlos III (ISCIII) 27 M € (Aprox.)
SPAIN
Two step procedure
Launch: 14th February 2018
Timeline: Submission deadline for Pre-proposals: 10th April 2018
Submission deadline for invited Full-proposals: 26th JuLY 2018ERAPerMed – EU co-funded JTC 2018
Scope of the call
TOPIC: RESEARCH PROJECTS ON PERSONALISED MEDICINE – SMART COMBINATION OF
PRE-CLINICAL AND CLINICAL RESEARCH WITH DATA AND ICT SOLUTIONSERAPerMed – EU co-funded JTC 2018
Facts and Figures
• Pre-proposal stage:
• 159/143 submitted projects
• 741 partners requesting to 30 funding organisations
• 176.21 M € requested funding
• 50 Pre-proposals invited to submit a Full proposal
• 75 evaluators from institutions affiliated to 24 countries (25%
females)
• Full proposal stage:
• 50 submitted projects
• 25 Proposals funded, 131 partners requesting to 21 funding
organisations.
• 28.27 M € requested funding
• 23 evaluators from institutions affiliated to 15 countriesERAPerMed – Content About ERA PerMed JTC 2018 JTC 2019 JTC 2020 Steps of a Call
ERAPerMed – non EU co-funded JTC 2019
17 EU countries
3 associated countries (to Horizon 2020):
Turkey, Norway, Israel
2 third countries: Canada and Egypt
6 regions (Saxony, Quebec, Lombardy,
30 Partners 22 Countries Navarra ,Cataluña and Tuscany
1 charity: AECC
Call Secretariat (JCS)
Agence National de la Recherche (ANR) Countries´ ex ante Budget
FRANCE 31.42 M €
Two step procedure
Launch: 9th January 2019
Submission deadline for Pre-proposals: 7th March 2019
Timeline: Submission deadline for invited Full-proposals: 17th June 2019
2020-Q1: Expected start of granted projects.ERAPerMed – non EU co-funded JTC 2019
Scope of the call
TOPIC: PERSONALIZED MEDICINE: MULTIDISCIPLINARY RESEARCH TOWARDS IMPLEMENTATION
Each consortium submitting a proposal must address at least one module of Research
Area 3 and at least one module of Research Area 1 or 2
Proposals must be interdisciplinary and clearly demonstrate the potential impact in
Personalized Medicine as well as the added value of transnational collaborationERAPerMed –non EU co-funded JTC2019
Facts and Figures
• Pre-proposal stage:
• 196 submitted projects
• 906 partners requesting to 30 funding organisations (27 own funding)
• 216 M € requested funding
• 56 Pre-proposals invited to submit a Full proposal
• 102 evaluators from institutions affiliated to 26 countries (33% females)
• Full proposal stage:
• 56 submitted projects
• 22 Proposals expected to be funded, 108 partners requesting to 24
funding organisations (5 partners on own funding).
• 24.6 M € requested funding
• 29 evaluators from institutions affiliated to 17 countriesERAPerMed – Content About ERA PerMed JTC 2018 JTC 2019 JTC 2020 Steps of a Call
ERAPerMed – non EU co-funded JTC 2020
17 EU countries
3 associated countries (to Horizon 2020):
Turkey, Norway, Israel
3 third countries: Canada, Egypt, Panama
34 Partners 23 Countries 6 regions (Saxony, Wallonia, Lombardy,
Navarra ,Cataluña and Tuscany)
Call Secretariat (JCS) 1 charity: AECC
German Aerospace Center (DLR)
GERMANY Countries´ ex ante Budget
23 M € approx.
Two step procedure
Launch: December 2019
Timeline: Submission deadline for Pre-proposals: March 2020
Submission deadline for invited Full-proposals: June 2020
PRE-ANNOUNCEMENT JTC 2020 ALREADY ONLINE
http://www.erapermed.eu/category/news/ERAPerMed – non EU co-funded JTC 2020
Scope of the call
TOPIC: “PERSONALISED MEDICINE – PRE-/CLINICAL RESEARCH, BIG
DATA AND ICT, IMPLEMENTATION AND USER’S PERSPECTIVE”
Each project proposal MUST address at least one module of
Research Area 3 and at least one module of Research Area 1 or 2.Partnering Tool https://partnering.pt-dlr.de/ICPerMed
ERAPerMed – Content About ERA PerMed JTC 2018 JTC 2019 JTC 2020 Steps of a Call
• Application done by each given
• Proposal by Coordinator participant (coordinator or
Reception of Reception de
• (received by the Call partner) research group to its
Secretariat) Proposals Solicitudes given Regional/national funding
organization
• Central Eligibility
• Selection of evaluators International Nacional/
• National/Regional Eligibility
• Remote and face-to-face Phase(s) Regional Phase
phace(s)
• Committed funds
Rules Ranking list Available funds • Possible national/ regional
increments
Selection of Projects
to be funded
National/ Steps of an
Regional Funding
process ERA-NET Call
Follow up:
• National/Regional
• InternationalInternational Eligibility (central) Criteria • Each consortium must involve at least 3 partners eligible for funding. (From a participating national/regional FO). • At least 3 different countries. • Maximum two participants per country. • Project coordinator must be eligible to be funded. • The maximum number of partners per project is 6 (7 if underrepresented) • No more than two partners from the same country. • No more than one partner with its own funding is allowed. * Each FO has its own national/regional eligibility criteria
International Eligibility (central) Criteria
FURTHER REQUIREMENTS
• Type of eligible organisation (variable);
Academia or research institutes; Clinical/public health sector;
(Industry) Private partners, e.g. SMEs. Patient organisations.
(depends upon the given FO)
• The proposal must comply with the topic of the call.
• Each partner represented by a single (PI).
• Comply with the formats required in the application
documents/online tool.
Full-proposal
Number of partners in the Pre-proposal
(only by inclusion of one underrepresented country)
proposal
3 4 5 6 7
Maximum number of partners
0 1 1 1 1
with own funding
Maximum number of partners ERAPerMed
1 2 2 Convocatoria
2 2019 2
per countrySteps for International Submission st 1 Phase (Pre-proposal) • Register in the corresponding online tool (Coordinator)
Steps for International Submission
st
1 Phase (Pre-proposal)
• Important. Obtain and read all relevant
documents:
1. Central: Call Text, Participant's Guidelines,
Pre-proposal Form, Templates required by the
Secretariat (DMP, Exploratory Clinical Studies).
2. National/regional; e.g. pre-eligibility forms.Steps for International Submission st 1 Phase (Pre-proposal) • To be submitted only by Coordinator and in English. • Comply with the required formats in each document to be submitted; DIN-A4, Calibri 11, a single space, maximum number of pages per section, in PDF, maximum 8 megabites. • Comply with deadlines, in date and time (the server closes). • Comply with the requirements regional/national funding agency where you are eligible. • Make sure you provide an appropriate contact email.
Steps for International Submission
nd
2 Phase (Full Proposal)
.
• Obtain and read all relevant documents: Full proposal
template.
• To be submitted only by Coordinator and in English.
• Comply required formats.
• Comply with online limits in date and time.
• Be aware of the rebuttal ("reply period"). Information sent
only to the Coordinator's email.Evaluation Process • 2-stage calls (pre-proposal and full proposal). • Remote and face-to-face peer review evaluation panels. • At least 3 evaluations per project. • Evaluation criteria: Excellence, Impact and Implementation of the project. • Panel between 50 and 90 experts for remote evaluation and between 15 and 25 evaluators for face-to-face evaluation. • Score from 0 to 5 per criterion (Total from 0 to 15 points). • There may be a threshold for criteria and/or a threshold for total score.
Evaluation Process
Evaluators are selected by:
I. Scientific adequacy (fitting expertise).
II. Availability during the phases of the evaluation
process.
III. Gender balance.
IV. Geographical balance.
V. No Conflicts of Interest.
VI. Preference if previous experience in
evaluation panels.
• Confidentiality agreement is required.Evaluation Process
A disqualifying Conflict of Interest (CoI) exists if an expert:
- was involved in the preparation of the proposal;
- stands to benefit directly should the proposal be accepted;
- has a close family relationship (relatives until second degree) with any person representing an applicant
institution in the proposal;
- is a director, trustee or partner of an applicant organisation;
- is employed by one of the applicant organisations in a proposal;
- is in any other situation that compromises his or her ability to evaluate the proposal impartially.
A potential conflict of interest may exist, even in cases not covered by the clear disqualifying conflicts indicated
above, if an expert:
- was employed by one of the applicant institutions in a proposal within the previous three years;
- is involved in a contract or research collaboration (including publications) with an applicant or has been so in the
previous three years;
- is in any other situation that could cast doubt on his or her ability to evaluate the proposal impartially, or that
could reasonably appear to do so in the eyes of an external third party.
In the case of a conflict of interest, the Joint Call Secretariat has to be informed immediately so that a substitute can
be found.
At the PRP meeting, reviewers should not be present when discussing their host institution’s application or other
proposals with conflicts of interests. In the case of a conflict of interest, they will be asked to leave the room.Evaluation steps Reception of Pre- Phase 1
Proposals
Pre-Proposal
National/
Regional Assignment of
Eligibility Central eligibility
evaluators
Remote
evaluation
• Preliminary Ranking list
• PRP
Face-to-Face
evaluation
2 to 3 times
Rules Ranking list available funds
Selection of consortia
Coordinators are
• CSC Meeting invited to Submit a Full
informed
ProposalEvaluation steps Reception of Full Phase 2
Proposals
Full Proposal
National/
Regional Assignment of
Eligibility Central eligibility
evaluators
Remote evaluation
• Evaluators’ reports
• Preliminary Ranking list
• Optional for participants Rebuttal period
• PRP Face-to-Face evaluation
• Committed funds
Rules Available
Final Ranking List • Possible national/
funds regional increments
Selection of Projects Coordinators are
• CSC Meeting
to be Funded informedEjemplo de Lista de Prelación
SELECTED
Luxembour The
Rank FOR Germany Austria Belgium France Norway Slovakia Slovenia Spain TOTAL
g Netherlands
FUNDING
14 YES 597.000 250.000 - - - 435.000 - - - 225.000 1.507.000
14 YES 598.000 - 198.000 498.000 - - - - - - 1.294.000
14 YES 598.000 - - 250.000 283.000 - - - - - 1.131.000
13 YES 384.000 283.000 - - - - 60.000 210.000 150.000 - 1.087.000
13 YES 573.000 - - 409.000 - 219.000 - - - - 1.201.000
12 NO 600.000 - - - 299.000 - 120.000 168.000 - 225.000 1.412.000
12 NO 400.000 237.000 - 246.000 - - - - 100.000 - 983.000
12 NO 600.000 - - 208.000 - 435.000 - - - 225.000 1.468.000
12 NO 600.000 - - - - 650.000 - - - 225.000 1.475.000
11 NO - - 200.000 248.000 - 647.000 - - - - 1.095.000
11 NO - - - 250.000 - - - 210.000 123.000 - 583.000
11 NO 444.000 - - 294.000 300.000 - - - - - 1.038.000
11 NO 245.000 212.000 - - - - - 186.000 - - 643.000
9 NO 600.000 - - - - - - - 100.000 225.000 925.000
9 NO - 250.000 - 534.000 - - - 160.000 - - 944.000
9 NO 600.000 - 120.000 198.000 - - - - - - 918.000
8 NO 399.000 250.000 - 228.000 - - - - - - 877.000
TOTAL
REQUESTED 7.238.000 1.482.000 518.000 3.363.000 882.000 2.386.000 180.000 934.000 473.000 1.125.000 18.581.000
FUNDING
NATIONAL/REGION 2.000.000 500.000 200.000 1.000.000 300.000 1.200.000 120.000 210.000 500.000 450.000 6.480.000
AL COMMITMENTPARTICIPATION ADAVANTAGES As Funding Organization (FO): • Strength the international position of the given FO. • Enhance the networking and quality of their research teams. • Reduce health R&D cost by aligning expenses with other countries/regions (avoiding double funding). • Middle and long term run socio-economic impacts by improving national/regional health service and/or new employment lines linked to enhancement of the health sector industry. As Researcher: • Receiving funding for their research. • Strength the networking and international position. • Knowledge/technology transfer. • Helps/ encourage researchers to become entrepreneurs.
Thank you for your
attention!
Contact: Mauricio Garcia-Franco, PhD mauriciog@isciii.es
COORDINATION UNIT
EULAC-PerMed Summer School
Personalised Medicine Research in the Health SystemYou can also read
